Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | Lapatinib | 0.1 | uM | 10 | 312.50 | 120.45 | 1003.00 | 507.00 | 1.9783 | 1.7792 |
| MDA-MB-231 | Lapatinib | 0.031623 | uM | 10 | 312.50 | 120.45 | 990.00 | 507.00 | 1.9527 | 1.7618 |
| MDA-MB-231 | Linsitinib | 3.1623 | uM | 10 | 312.50 | 120.45 | 887.00 | 507.00 | 1.7495 | 1.6193 |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 904.00 | 507.00 | 1.7830 | 1.6434 | |
| MDA-MB-231 | Erlotinib | 0.1 | uM | 10 | 312.50 | 120.45 | 813.00 | 507.00 | 1.6036 | 1.5115 |
| MDA-MB-231 | Linsitinib | 0.31623 | uM | 10 | 312.50 | 120.45 | 693.00 | 507.00 | 1.3669 | 1.3253 |
| MDA-MB-231 | Linsitinib | 0.1 | uM | 10 | 312.50 | 120.45 | 774.00 | 507.00 | 1.5266 | 1.4527 |
| MDA-MB-231 | Erlotinib | 1 | uM | 10 | 312.50 | 120.45 | 636.00 | 507.00 | 1.2544 | 1.2311 |
| MDA-MB-231 | Linsitinib | 19.9526 | uM | 10 | 312.50 | 120.45 | 263.00 | 507.00 | 0.5187 | 0.4573 |
| MDA-MB-231 | Erlotinib | 0.031623 | uM | 10 | 312.50 | 120.45 | 725.00 | 507.00 | 1.4300 | 1.3765 |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 469.00 | 507.00 | 0.9251 | 0.9263 | |
| MDA-MB-231 | 17-AAG | 3.1623 | uM | 10 | 312.50 | 120.45 | 133.00 | 507.00 | 0.2623 | 0.0489 |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 470.00 | 507.00 | 0.9270 | 0.9282 | |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 478.00 | 507.00 | 0.9428 | 0.9440 | |
| MDA-MB-231 | 17-AAG | 10 | uM | 10 | 312.50 | 120.45 | 129.00 | 507.00 | 0.2544 | 0.0336 |
| MDA-MB-231 | 17-AAG | 0.0016596 | uM | 10 | 312.50 | 120.45 | 575.00 | 507.00 | 1.1341 | 1.1252 |
| MDA-MB-231 | Lapatinib | 0.0033113 | uM | 10 | 312.50 | 120.45 | 647.00 | 507.00 | 1.2761 | 1.2496 |
| MDA-MB-231 | Erlotinib | 0.01 | uM | 10 | 312.50 | 120.45 | 719.00 | 507.00 | 1.4181 | 1.3670 |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 638.00 | 507.00 | 1.2584 | 1.2344 | |
| MDA-MB-231 | Erlotinib | 3.1623 | uM | 10 | 312.50 | 120.45 | 608.00 | 507.00 | 1.1992 | 1.1831 |
| MDA-MB-231 | Lapatinib | 0.0016596 | uM | 10 | 312.50 | 120.45 | 806.00 | 507.00 | 1.5897 | 1.5011 |
| MDA-MB-231 | Linsitinib | 1 | uM | 10 | 312.50 | 120.45 | 765.00 | 507.00 | 1.5089 | 1.4389 |
| MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 312.50 | 120.45 | 753.00 | 507.00 | 1.4852 | 1.4204 |
| MDA-MB-231 | Linsitinib | 0.0033113 | uM | 10 | 312.50 | 120.45 | 979.00 | 507.00 | 1.9310 | 1.7470 |
| MDA-MB-231 | 17-AAG | 0.31623 | uM | 10 | 312.50 | 120.45 | 763.00 | 507.00 | 1.5049 | 1.4358 |